We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Terminal sterilized and non terminal sterilized Water injection, lyophilized injection powder, IV solution and other medicine.
Main characteristic:
1. Achieve full time weighing detect of Whole process and automatically feedback the information to adjust filling volume. Working principle of domestic existing type is: firstly take out bottles, weighing then filling, then get bottle for weighing again then take back for closing, this may cause cross-contamination and omission. But our on-line whole process of weighing detection can avoid such kind of risk.
2. Using straight-line stopperring, will not disrupt laminar flow, can be fully avoided rotation filling block of laminar flow and mixed flow caused by rotation, turbulence, avoid cross contamination risks, so meet the new GMP requirements.
3. “0 risk” designing according to the most advance international new concept, there is no mechanical transmission chain on machine table, no dead area, and machine table completed separated from transmission box, so that no friction dusts and oil pollution, which is the pioneer in China, and it’s the upgrade product of the same products.
Two years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
